2023 Q3 Form 10-Q Financial Statement

#000143774923023115 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q4
Revenue $10.89M $10.14M $8.673M
YoY Change 29.36% 43.54% 26.43%
Cost Of Revenue $6.230M $5.921M $5.580M
YoY Change 34.2% 23.45%
Gross Profit $4.658M $4.219M $3.093M
YoY Change 59.09% 32.18%
Gross Profit Margin 42.78% 41.61% 35.66%
Selling, General & Admin $2.625M $2.119M $2.265M
YoY Change 3.42% 5.74%
% of Gross Profit 56.35% 50.23% 73.23%
Research & Development $566.0K $535.0K
YoY Change
% of Gross Profit 12.15% 12.68%
Depreciation & Amortization $205.0K $204.0K $199.0K
YoY Change 10.22% 13.97% 30.92%
% of Gross Profit 4.4% 4.84% 6.43%
Operating Expenses $2.625M $2.654M $2.265M
YoY Change -66.29% 29.53% 5.74%
Operating Profit $2.033M $1.565M $828.0K
YoY Change 222.7% 159.54% 318.18%
Interest Expense -$5.000K -$5.000K
YoY Change 150.0% 66.67%
% of Operating Profit -0.32% -0.6%
Other Income/Expense, Net $13.00K $17.00K -$233.0K
YoY Change -181.25% -288.89% 2230.0%
Pretax Income $2.046M $1.582M $595.0K
YoY Change 233.22% 167.23% 221.62%
Income Tax $460.0K $305.0K $405.0K
% Of Pretax Income 22.48% 19.28% 68.07%
Net Earnings $1.586M $1.277M $190.0K
YoY Change 215.31% 162.76% 630.77%
Net Earnings / Revenue 14.57% 12.59% 2.19%
Basic Earnings Per Share $0.59 $0.47 $0.07
Diluted Earnings Per Share $0.57 $0.47 $0.05
COMMON SHARES
Basic Shares Outstanding 2.727M 2.727M 2.727M
Diluted Shares Outstanding 2.760M 2.711M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.552M $1.321M $926.0K
YoY Change 216.63% 19.76% -64.86%
Cash & Equivalents $2.552M $1.321M $926.0K
Short-Term Investments
Other Short-Term Assets $419.0K $327.0K $673.0K
YoY Change 195.07% 53.52% 178.1%
Inventory $8.962M $8.713M $7.518M
Prepaid Expenses
Receivables $5.031M $5.745M $5.197M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.96M $16.11M $14.31M
YoY Change 24.9% 36.8% 18.37%
LONG-TERM ASSETS
Property, Plant & Equipment $3.635M $3.564M $3.647M
YoY Change 2.14% -2.28% 7.84%
Goodwill $40.00K
YoY Change 0.0%
Intangibles $58.00K $71.00K $98.00K
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.00K $13.00K $16.00K
YoY Change -33.33% -99.79% 220.0%
Total Long-Term Assets $4.821M $4.789M $4.959M
YoY Change -52.73% -51.51% -37.33%
TOTAL ASSETS
Total Short-Term Assets $16.96M $16.11M $14.31M
Total Long-Term Assets $4.821M $4.789M $4.959M
Total Assets $21.79M $20.90M $19.27M
YoY Change -8.39% -3.49% -3.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.418M $1.811M $2.381M
YoY Change -52.34% 14.33% 70.56%
Accrued Expenses $2.471M $2.316M $2.241M
YoY Change 47.79% 46.68% 38.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.992M $4.772M $4.856M
YoY Change -15.53% 47.51% 61.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $40.00K $42.00K $76.00K
YoY Change -56.04% -62.5% -47.59%
Total Long-Term Liabilities $40.00K $42.00K $76.00K
YoY Change -56.04% -62.5% -47.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.992M $4.772M $4.856M
Total Long-Term Liabilities $40.00K $42.00K $76.00K
Total Liabilities $4.032M $4.814M $4.932M
YoY Change -16.3% 43.83% 56.22%
SHAREHOLDERS EQUITY
Retained Earnings $3.628M $2.042M $212.0K
YoY Change
Common Stock $14.13M $14.04M $14.13M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.75M $16.08M $14.34M
YoY Change
Total Liabilities & Shareholders Equity $21.79M $20.90M $19.27M
YoY Change -8.39% -3.49% -3.66%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income $1.586M $1.277M $190.0K
YoY Change 215.31% 162.76% 630.77%
Depreciation, Depletion And Amortization $205.0K $204.0K $199.0K
YoY Change 10.22% 13.97% 30.92%
Cash From Operating Activities $1.494M $500.0K $837.0K
YoY Change 519.92% -55.52% -47.49%
INVESTING ACTIVITIES
Capital Expenditures $263.0K $224.0K $273.0K
YoY Change -198.13% -219.15% -180.29%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$263.0K -$224.0K -$273.0K
YoY Change -1.87% 19.15% -19.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -82.00K -444.0K
YoY Change -100.0% -94.11% -3.9%
NET CHANGE
Cash From Operating Activities 1.494M 500.0K 837.0K
Cash From Investing Activities -263.0K -224.0K -273.0K
Cash From Financing Activities 0.000 -82.00K -444.0K
Net Change In Cash 1.231M 194.0K 120.0K
YoY Change -514.48% -142.45% -84.85%
FREE CASH FLOW
Cash From Operating Activities $1.494M $500.0K $837.0K
Capital Expenditures $263.0K $224.0K $273.0K
Free Cash Flow $1.231M $276.0K $564.0K
YoY Change 141.85% -78.96% -70.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
112000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
142000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2725670
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2725670
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2726798
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2726798
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9710
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41391
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-0457944
dei Entity Address Address Line1
EntityAddressAddressLine1
2525 Shader Rd.
dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32804
dei City Area Code
CityAreaCode
407
dei Local Phone Number
LocalPhoneNumber
298-2000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01
dei Trading Symbol
TradingSymbol
MPTI
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2727125
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10140000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7064000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19507000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14755000 usd
CY2023Q2 us-gaap Manufacturing Costs
ManufacturingCosts
5921000 usd
CY2022Q2 us-gaap Manufacturing Costs
ManufacturingCosts
4412000 usd
us-gaap Manufacturing Costs
ManufacturingCosts
12092000 usd
us-gaap Manufacturing Costs
ManufacturingCosts
9231000 usd
CY2023Q2 mpti Engineering Selling And Administrative
EngineeringSellingAndAdministrative
2654000 usd
CY2022Q2 mpti Engineering Selling And Administrative
EngineeringSellingAndAdministrative
2049000 usd
mpti Engineering Selling And Administrative
EngineeringSellingAndAdministrative
5089000 usd
mpti Engineering Selling And Administrative
EngineeringSellingAndAdministrative
4107000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1565000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
603000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2326000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1417000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-26000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1582000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
592000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2301000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1386000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
305000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
106000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
471000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
281000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1277000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
486000 usd
us-gaap Net Income Loss
NetIncomeLoss
1830000 usd
us-gaap Net Income Loss
NetIncomeLoss
1105000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1321000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
926000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5745000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5197000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
8713000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
7518000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
327000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
673000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
16106000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
14314000 usd
CY2023Q2 us-gaap Land
Land
536000 usd
CY2022Q4 us-gaap Land
Land
536000 usd
CY2023Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
4937000 usd
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
4937000 usd
CY2023Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
19345000 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
19044000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24818000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24517000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21254000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20870000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3564000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3647000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
110000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
147000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
71000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
98000 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1031000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1051000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16000 usd
CY2023Q2 us-gaap Assets
Assets
20895000 usd
CY2022Q4 us-gaap Assets
Assets
19273000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1811000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2381000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1704000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1627000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
612000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
614000 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
645000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
234000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4772000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4856000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
42000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
76000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
4814000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4932000 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
27000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
27000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
14012000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
14102000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2042000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
212000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16081000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
14341000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20895000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19273000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
14341000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
553000 usd
CY2023Q1 mpti Adjustments To Additional Paid In Capital Transfers To Former Parent
AdjustmentsToAdditionalPaidInCapitalTransfersToFormerParent
-219000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
71000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
14746000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1277000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
140000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
82000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16081000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16849000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
619000 usd
CY2022Q1 mpti Equity Transfers To Former Parent
EquityTransfersToFormerParent
240000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
17708000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
486000 usd
CY2022Q2 mpti Equity Transfers To Former Parent
EquityTransfersToFormerParent
109000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
18303000 usd
us-gaap Net Income Loss
NetIncomeLoss
1830000 usd
us-gaap Net Income Loss
NetIncomeLoss
1105000 usd
us-gaap Depreciation
Depreciation
385000 usd
us-gaap Depreciation
Depreciation
313000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
211000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
287000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
20000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
214000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
548000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
334000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1195000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
907000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-349000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-34000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-300000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
225000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
779000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
964000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
302000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
395000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-302000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-395000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
82000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
mpti Net Transfers From To Former Parent
NetTransfersFromToFormerParent
0 usd
mpti Net Transfers From To Former Parent
NetTransfersFromToFormerParent
62000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
-0 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
20000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2143000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-82000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2101000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
395000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1532000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
926000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2635000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1321000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1103000 usd
us-gaap Interest Paid Net
InterestPaidNet
7000 usd
us-gaap Interest Paid Net
InterestPaidNet
5000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
97000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
16000 usd
CY2022Q4 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2676469
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2697696
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2676469
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2688065
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2676469
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
13570
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
21513
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2711266
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2676469
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2709578
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2676469
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9710
us-gaap Fiscal Period
FiscalPeriod
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Interim Financial Statements</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Consolidated and Combined Financial Statements as of and for the <em style="font: inherit;">three</em> and <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022</em> are unaudited. These Consolidated and Combined Financial Statements should be read in conjunction with the audited Consolidated and Combined Financial Statements and notes thereto for the fiscal years ended <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021</em>, contained within the Company’s Annual Report on Form <em style="font: inherit;">10</em>-K, filed with the Securities and Exchange Commission (the “SEC”) on <em style="font: inherit;"> March 30, 2023.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In the opinion of management, the accompanying Consolidated and Combined Financial Statements reflect all adjustments, which are of a normal recurring nature and necessary for a fair presentation of the results for the interim periods.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of the Consolidated and Combined Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p>
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1064000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
981000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Concentration Risks</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the <em style="font: inherit;">three</em> and <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2023</em>, the Company's largest customer accounted for $2,723,000, or 26.9%, and $5,057,000, or 25.9%, of the Company's total revenues, respectively, compared to $2,110,000, or 29.9%, and $4,173,000, or 28.3%, of the Company’s total revenues for the <em style="font: inherit;">three</em> and <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2022</em>, respectively. For the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022,</em> the Company’s <em style="font: inherit;">second</em> largest customer accounted for $1,662,000, or 16.4%, compared to $884,000, or 11.3%, of the Company’s total revenues, respectively, and for the <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022</em> the <em style="font: inherit;">second</em> largest customer accounted for $2,671,000, or 13.7%, compared to $1,803,000, or 12.2%, of the Company’s total revenues, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A significant portion of the Company's accounts receivable is concentrated with a relatively small number of customers. As of <em style="font: inherit;"> June 30, 2023</em>, four of the Company's largest customers accounted for approximately $3,932,000, or 68.4%, of accounts receivable. As of <em style="font: inherit;"> December </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2022,</em> <span style="-sec-ix-hidden:c101621001">four</span> of the Company's largest customers accounted for approximately <em style="font: inherit;">$2,872,000,</em> or 53.8%, of accounts receivable. The Company carefully evaluates the creditworthiness of its customers in deciding to extend credit. As a result, the Company has experienced very low historical bad debt expense and believes the related risk to be minimal.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p>
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3173000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1515000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1502000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1318000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3648000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3335000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3550000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1010000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
8713000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
7518000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.205 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.203 pure
CY2023Q2 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
0 usd

Files In Submission

Name View Source Status
0001437749-23-023115-index-headers.html Edgar Link pending
0001437749-23-023115-index.html Edgar Link pending
0001437749-23-023115.txt Edgar Link pending
0001437749-23-023115-xbrl.zip Edgar Link pending
ex_525050.htm Edgar Link pending
ex_525051.htm Edgar Link pending
ex_525052.htm Edgar Link pending
ex_525053.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mpti-20230630.xsd Edgar Link pending
mpti20230630_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mpti-20230630_lab.xml Edgar Link unprocessable
mpti-20230630_def.xml Edgar Link unprocessable
mpti-20230630_pre.xml Edgar Link unprocessable
mpti20230630_10q_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mpti-20230630_cal.xml Edgar Link unprocessable